198 related articles for article (PubMed ID: 36624505)
1. Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial.
Green JE; McGuinness AJ; Berk M; Castle D; Athan E; Hair C; Strandwitz P; Loughman A; Nierenberg AA; Cryan JF; Mohebbi M; Jacka F
Pilot Feasibility Stud; 2023 Jan; 9(1):5. PubMed ID: 36624505
[TBL] [Abstract][Full Text] [Related]
2. Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
Green JE; Berk M; Mohebbi M; Loughman A; McGuinness AJ; Castle D; Chatterton ML; Perez J; Strandwitz P; Athan E; Hair C; Nierenberg AA; Cryan JF; Jacka F
Can J Psychiatry; 2023 May; 68(5):315-326. PubMed ID: 36637229
[TBL] [Abstract][Full Text] [Related]
3. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis.
Quraishi MNN; Yalchin M; Blackwell C; Segal J; Sharma N; Hawkey P; McCune V; Hart AL; Gaya D; Ives NJ; Magill L; Loi S; Hewitt C; Gerasimidis K; Loman NJ; Hansen R; McMullan C; Mathers J; Quince C; Crees N; Iqbal T
BMJ Open; 2019 Nov; 9(11):e030659. PubMed ID: 31719078
[TBL] [Abstract][Full Text] [Related]
4. Safety and feasibility of faecal microbiota transplantation for patients with Parkinson's disease: a protocol for a self-controlled interventional donor-FMT pilot study.
Vendrik KE; Chernova VO; Kuijper EJ; Terveer EM; van Hilten JJ; Contarino MF;
BMJ Open; 2023 Oct; 13(10):e071766. PubMed ID: 37798034
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of fecal microbiota transplantation in a population with bipolar disorder during depressive episodes: study protocol for a pilot randomized controlled trial.
Cooke NCA; Bala A; Allard JP; Hota S; Poutanen S; Taylor VH
Pilot Feasibility Stud; 2021 Jul; 7(1):142. PubMed ID: 34261526
[TBL] [Abstract][Full Text] [Related]
6. Protocol for faecal microbiota transplantation in ulcerative colitis (FMTUC): a randomised feasibility study.
Jitsumura M; Cunningham AL; Hitchings MD; Islam S; Davies AP; Row PE; Riddell AD; Kinross J; Wilkinson TS; Jenkins GJ; Williams JG; Harris DA
BMJ Open; 2018 Oct; 8(10):e021987. PubMed ID: 30341117
[TBL] [Abstract][Full Text] [Related]
7. Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn's disease population: PediCRaFT Trial.
Pai N; Popov J; Hill L; Hartung E
BMJ Open; 2019 Nov; 9(11):e030120. PubMed ID: 31784432
[TBL] [Abstract][Full Text] [Related]
8. Just a gut feeling: Faecal microbiota transplant for treatment of depression - A mini-review.
Chang M; Chang KT; Chang F
J Psychopharmacol; 2024 Apr; 38(4):353-361. PubMed ID: 38532577
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial.
Hoffmann-Vold AM; Fretheim HH; Sarna VK; Barua I; Carstens MN; Distler O; Khanna D; Volkmann ER; Midtvedt Ø; Didriksen H; Dhainaut A; Halse AK; Bakland G; Pesonen M; Olsen I; Molberg Ø
BMJ Open; 2021 Jun; 11(6):e048541. PubMed ID: 34168032
[TBL] [Abstract][Full Text] [Related]
10. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial.
Woodhouse CA; Patel VC; Goldenberg S; Sanchez-Fueyo A; China L; O'Brien A; Flach C; Douiri A; Shawcross D
BMJ Open; 2019 Feb; 9(2):e023518. PubMed ID: 30772848
[TBL] [Abstract][Full Text] [Related]
11. The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study.
Chinna Meyyappan A; Sgarbossa C; Vazquez G; Bond DJ; Müller DJ; Milev R
JMIR Res Protoc; 2021 Sep; 10(9):e31439. PubMed ID: 34550085
[TBL] [Abstract][Full Text] [Related]
12. FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder.
Chen Y; Xueying Z; Jiaqu C; Qiyi C; Huanlong Q; Ning L; Yasong D; Xiaoxin Z; Rong Y; Jubao L; Xiaoqiong L; Chunlian M; Yu W; Shidong C; Guifang K; Dongmei Z; Shuanfeng F; Xujing Z; Binrang Y; Yanxia W; Ling L; Song Y; Xiang Z; Beihua Z; Lin J; Hong J;
BMJ Open; 2022 Jan; 12(1):e051613. PubMed ID: 35105621
[TBL] [Abstract][Full Text] [Related]
13. Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy.
Cold F; Baunwall SMD; Dahlerup JF; Petersen AM; Hvas CL; Hansen LH
Therap Adv Gastroenterol; 2021; 14():17562848211041004. PubMed ID: 34484424
[TBL] [Abstract][Full Text] [Related]
14. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
[TBL] [Abstract][Full Text] [Related]
15. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study.
Halkjær SI; Christensen AH; Lo BZS; Browne PD; Günther S; Hansen LH; Petersen AM
Gut; 2018 Dec; 67(12):2107-2115. PubMed ID: 29980607
[TBL] [Abstract][Full Text] [Related]
16. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
Johnsen PH; Hilpüsch F; Cavanagh JP; Leikanger IS; Kolstad C; Valle PC; Goll R
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):17-24. PubMed ID: 29100842
[TBL] [Abstract][Full Text] [Related]
17. Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial.
Zeevenhooven J; de Bruijn CMA; Vlieger A; Nieuwdorp M; Benninga MA
BMJ Paediatr Open; 2020; 4(1):e000689. PubMed ID: 32864480
[TBL] [Abstract][Full Text] [Related]
18. An open-label pilot trial of faecal microbiome transfer to restore the gut microbiome in anorexia nervosa: protocol.
Wilson BC; Derraik JGB; Albert BB; Leong KSW; Tweedie-Cullen RY; Creagh C; Depczynski M; Edwards T; Vatanen T; Thabrew H; Cutfield WS; O'Sullivan JM
BMJ Open; 2023 Jul; 13(7):e070616. PubMed ID: 37429676
[TBL] [Abstract][Full Text] [Related]
19. Pick fecal microbiota transplantation to enhance therapy for major depressive disorder.
Meng Y; Sun J; Zhang G
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110860. PubMed ID: 37678703
[TBL] [Abstract][Full Text] [Related]
20. Clinical results and microbiota changes after faecal microbiota transplantation for chronic pouchitis: a pilot study.
Kousgaard SJ; Michaelsen TY; Nielsen HL; Kirk KF; Brandt J; Albertsen M; Thorlacius-Ussing O
Scand J Gastroenterol; 2020 Apr; 55(4):421-429. PubMed ID: 32285709
[No Abstract] [Full Text] [Related]
[Next] [New Search]
